La trimetazidina disminuye la glicemia basal en ratas con hiperglicemia de ayuno

Cano, Clímaco; Bermedez, Valmore; Souki, Aida; Amell, Anilsa; Restrepo, Helen; Leal, Elliuz; Espinoza, Santiago; Seyfi, Hamid; Arria, Melissa; Rojas, Joselyn; Medina, Mayerlim; Nerez, Maryluz; Bermedez, Fernando.
Arch. venez. farmacol. ter ; 19(1): 58-61, 2000. tab
Artículo en Español | LILACS | ID: lil-325690

Documentos relacionados

  1. Trimetazidine Affects Mitochondrial Calcium Uniporter Expression to Restore Ischemic Heart Function via Reactive Oxygen Species/NFκB Pathway Inhibition.
  2. [Treatment of Patients With Stable Ischemic Heart Disease in Real Clinical Practice in Russia. The CHOICE-2 Program].
  3. The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients.
  4. Current Clinical Evidence of Trimetazidine in the Management of Heart Disease in Patients with Diabetes.
  5. The role of postoperative trimetazidine therapy in on-pump coronary artery bypass surgery.
  6. [State of the art management of patients presenting an ischemia with non-obstructive coronary arteries (ANOCA/INOCA)].
  7. Managing Ischemic Heart Disease in Women: Role of a Women's Heart Center.
  8. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
  9. [CURRENT VIEWS OF DIAGNOSTICS AND STRATEGY OF THE TREATMENT OF STABLE ISCHEMIC HEART DISEASE].
  10. Coronary microvascular dysfunction.